KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Vertex Pharmaceuticals (VRTX) EPS (Basic) (2016 - 2025)

Historic EPS (Basic) for Vertex Pharmaceuticals (VRTX) over the last 17 years, with Q4 2025 value amounting to $4.69.

  • Vertex Pharmaceuticals' EPS (Basic) rose 3286.12% to $4.69 in Q4 2025 from the same period last year, while for Dec 2025 it was $15.47, marking a year-over-year increase of 84375.0%. This contributed to the annual value of $15.46 for FY2025, which is 84326.92% up from last year.
  • Per Vertex Pharmaceuticals' latest filing, its EPS (Basic) stood at $4.69 for Q4 2025, which was up 3286.12% from $4.24 recorded in Q3 2025.
  • Over the past 5 years, Vertex Pharmaceuticals' EPS (Basic) peaked at $4.69 during Q4 2025, and registered a low of -$13.92 during Q2 2024.
  • For the 5-year period, Vertex Pharmaceuticals' EPS (Basic) averaged around $2.47, with its median value being $3.42 (2021).
  • As far as peak fluctuations go, Vertex Pharmaceuticals' EPS (Basic) skyrocketed by 111923.08% in 2022, and later plummeted by 49211.27% in 2024.
  • Over the past 5 years, Vertex Pharmaceuticals' EPS (Basic) (Quarter) stood at $2.99 in 2021, then grew by 7.0% to $3.2 in 2022, then rose by 17.59% to $3.76 in 2023, then fell by 6.12% to $3.53 in 2024, then soared by 32.86% to $4.69 in 2025.
  • Its last three reported values are $4.69 in Q4 2025, $4.24 for Q3 2025, and $4.02 during Q2 2025.